Blueprint Medicines (BPMC) Tops Q1 EPS by 6c, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. LEN
8. USO
9. LMT
10. AMZN

Go back to Blueprint Medicines (BPMC) Tops Q1 EPS by 6c, Revenues Beat

Blueprint Medicines Reports First Quarter 2020 Financial Results

May 6, 2020 7:01 AM EDT

CAMBRIDGE, Mass., May 6, 2020 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today reported financial results and provided a business update for the first quarter ended March 31, 2020.

"Our progress in recent months is a... More